Loading...
Please wait, while we are loading the content...
Similar Documents
Induced Pluripotent Stem Cells to Model Juvenile Myelomonocytic Leukemia: New Perspectives for Preclinical Research
| Content Provider | MDPI |
|---|---|
| Author | Wehbe, Zeinab Ghanjati, Foued Flotho, Christian |
| Copyright Year | 2021 |
| Description | Juvenile myelomonocytic leukemia (JMML) is a malignant myeloproliferative disorder arising in infants and young children. The origin of this neoplasm is attributed to an early deregulation of the Ras signaling pathway in multipotent hematopoietic stem/progenitor cells. Since JMML is notoriously refractory to conventional cytostatic therapy, allogeneic hematopoietic stem cell transplantation remains the mainstay of curative therapy for most cases. However, alternative therapeutic approaches with small epigenetic molecules have recently entered the stage and show surprising efficacy at least in specific subsets of patients. Hence, the establishment of preclinical models to test novel agents is a priority. Induced pluripotent stem cells (IPSCs) offer an opportunity to imitate JMML ex vivo, after attempts to generate immortalized cell lines from primary JMML material have largely failed in the past. Several research groups have previously generated patient-derived JMML IPSCs and successfully differentiated these into myeloid cells with extensive phenotypic similarities to primary JMML cells. With infinite self-renewal and the capability to differentiate into multiple cell types, JMML IPSCs are a promising resource to advance the development of treatment modalities targeting specific vulnerabilities. This review discusses current reprogramming techniques for JMML stem/progenitor cells, related clinical applications, and the challenges involved. |
| Starting Page | 2335 |
| e-ISSN | 20734409 |
| DOI | 10.3390/cells10092335 |
| Journal | Cells |
| Issue Number | 9 |
| Volume Number | 10 |
| Language | English |
| Publisher | MDPI |
| Publisher Date | 2021-09-06 |
| Access Restriction | Open |
| Subject Keyword | Cells Cell Tissue Engineering Jmml Leukemia Reprogramming Ipsc Differentiation Hematopoietic Cells |
| Content Type | Text |
| Resource Type | Article |